Contact this trialFirst, we need to learn more about you.
Virus Therapy
Viral-Specific T-cell Therapy for Post-Transplant Viral Infections
Recruiting1 awardPhase 2
Memphis, Tennessee
This trial tests if donor T-cells can safely treat CMV & ADV infections post-transplant. The primary objective is to reduce viral load & secondary is to measure safety & long-term response.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.